华海药业：卡络磺钠注射液获药品注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the marketing of Carbetocin Injection, which is indicated for various bleeding disorders in the urinary system, upper digestive tract, respiratory tract, and gynecology [1] Group 1 - The approved product, Carbetocin Injection, is effective for urinary system conditions and can also be used for the prevention and treatment of surgical bleeding [1]